Get the Stockscreener App
178.58
0.21%
0.37
After Hours:
178.58
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $178.58, with a volume of 1.15M.
It is up +0.21% in the last 24 hours and down -0.01% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$178.21
Open:
$178.45
24h Volume:
1.15M
Relative Volume:
0.73
Market Cap:
$9.35B
Revenue:
$1.53B
Net Income/Loss:
$207.70M
P/E Ratio:
-64.39
EPS:
-2.7734
Net Cash Flow:
$193.10M
1W Performance:
+0.04%
1M Performance:
-0.01%
6M Performance:
+25.64%
1Y Performance:
+9.65%
1-Day Range:
$178.19
$178.58
1-Week Range:
$178.16
$178.60
52-Week Range:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
178.58 | 9.33B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corp. stockholders adopted Danaher merger agreement May 1 - MLex
Danaher to acquire Masimo (NASDAQ: MASI) in $180 per share cash deal - Stock Titan
Masimo (MASI) director gets new RSU grant and converts prior award - Stock Titan
Masimo (MASI) director awarded 1,119 RSUs and exercises 1,225 units - Stock Titan
Masimo (MASI) chair exercises 1,225 RSUs and receives 1,119-unit grant - Stock Titan
Masimo (MASI) CHRO nets RSU shares after tax-withholding share disposition - Stock Titan
Vanguard Group Inc. Sells 461,225 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Shareholders Approve $180 Per Share Acquisition by Danaher, Merger Expected to Close in 2026 - Minichart
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Masimo Shareholders Approve $9.9B Sale to Danaher - Orange County Business Journal
Masimo shareholders approve its $9.9B acquisition by Danaher - Modern Healthcare
Masimo Shareholders OK $9.9B Merger Deal with Danaher - Medical Product Outsourcing
Masimo shareholders approve $180 per share Danaher acquisition - Investing.com
Masimo (NASDAQ: MASI) shareholders back $180 cash acquisition by Danaher - Stock Titan
Masimo nears Danaher sale after shareholder vote backs cash merger - Stock Titan
Masimo Corporation $MASI Shares Purchased by UBS Group AG - MarketBeat
Is Masimo Corporation (MASI) A Good Stock To Buy Now? - Yahoo Finance
Masimo (MASI) 10-K/A adds governance, CEO pay terms and Danaher merger plans - Stock Titan
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones - Yahoo Finance
MASI Stock Price, Quote & Chart | MASIMO CORP (NASDAQ:MASI) - ChartMill
MSN Money - MSN
BlackRock (MASI) holds 116,871 shares of Masimo — 0.2% stake - Stock Titan
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
M&T Bank Corp Purchases 6,578 Shares of Masimo Corporation $MASI - MarketBeat
€2.98B Danaher (NYSE: DHR) euro notes to support Masimo acquisition - Stock Titan
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Masimo Drops Customs Suit After ITC Backs Apple Watch Redesign - Bloomberg Law News
Masimo Data Backs Pulse Ox Accuracy in Newborns Across All Skin Tones - Orange County Business Journal
Masimo (MASI) Study Shows High Accuracy of Pulse Oximetry in Neo - GuruFocus
Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study – Company AnnouncementFT.com - Financial Times
TechCon Global Announces Joe Kiani as Recipient of the TechCon Fellows Lifetime Achievement Award - TMX Newsfile
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Masimo Shareholder Notice - TMX Newsfile
Masimo Corporation $MASI Shares Bought by Cwm LLC - MarketBeat
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? - The Motley Fool
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
Masimo Corp SEC Filing 8-K: Company Information, Address, and Precedent Medical Device Transactions Analysis (2026) - Minichart
Masimo to supplement proxy after shareholder suits; merger terms unchanged - TradingView
[8-K] MASIMO CORP Reports Material Event - Stock Titan
Danaher (DHR) sells €3.0B of notes; proceeds to help fund Masimo acquisition - Stock Titan
To help fund its Masimo acquisition, Danaher prices €3B debt - Stock Titan
Chancery Sends Masimo Ex-CEO Pay Fight to California - Law360
[424B5] DANAHER CORP /DE/ Prospectus Supplement (Debt Securities) - Stock Titan
Apple fends off Masimo challenge to Apple Watch redesign - Yahoo Finance
Masimo (BSP:M2AS34) Securities & Investments - GuruFocus
Masimo Founder Kiani Gets Severance Dispute Sent to California - Bloomberg Law News
DHR Reports Strong Q1 Revenue and Plans Masimo Acquisition - GuruFocus
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Danaher (NYSE: DHR) posts Q1 2026 growth and plans $9.9B Masimo deal - Stock Titan
OC Medical Device Makers Workforce Returns to Growth - Orange County Business Journal
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):